BCAT Overview

BlackRock Capital Allocation Term Trust (Trust), formerly BlackRock Capital Allocation Trust, is a non-diversified, closed-end management investment company. The Trust’s investment objectives are to provide total return and income through a combination of current income, current gains, and long-term capital appreciation. The Trust invests in a portfolio of equity and debt securities. The Trust invest in all types of debt securities, including United States and foreign government bonds, corporate bonds, convertible bonds, municipal bonds, structured notes, credit-linked notes, loan assignments and participations, mortgage- and asset-backed securities, and securities issued or guaranteed by certain international organizations such as the World Bank. The Trust also buys debt securities of varying maturities, debt securities paying a fixed or fluctuating rate of interest, and debt securities of any kind. The Trust’s investment adviser is BlackRock Advisors, LLC.

Wall Street analysts forecast BCAT stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BCAT is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

BlackRock Capital Allocation Term Trust revenue for the last quarter amounts to NaN USD, decreased

BlackRock Capital Allocation Term Trust. EPS for the last quarter amounts to USD, decreased

BlackRock Capital Allocation Term Trust (BCAT) has 0 emplpoyees as of June 15 2026.

Today BCAT has the market capitalization of 0.00 USD.